Moreover, gene expression analysis in two human cancer types (ovarian cancer and chronic lymphocytic leukemia) unveiled a gradual decrease of RNASET2 gene expression with increasing stage or grade (which is an expected pattern for an oncosuppressor gene) (59). This evidence concerns the gene RNASET2 and ovarian carcinoma.